Dose Rates, Activity, and Shielding Transmission Factors for U235 Fission Products After Short Irradiation PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Dose Rates, Activity, and Shielding Transmission Factors for U235 Fission Products After Short Irradiation PDF full book. Access full book title Dose Rates, Activity, and Shielding Transmission Factors for U235 Fission Products After Short Irradiation by Donald A. McKown. Download full books in PDF and EPUB format.
Author: Donald A. McKown
Publisher:
ISBN:
Category : Fission products
Languages : en
Pages : 56
Get Book Here
Book Description
Author: Donald A. McKown
Publisher:
ISBN:
Category : Fission products
Languages : en
Pages : 56
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Aeronautics
Languages : en
Pages : 308
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category :
Languages : en
Pages : 156
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1388
Get Book Here
Book Description
Author: International Atomic Energy Agency
Publisher:
ISBN:
Category : Nuclear energy
Languages : en
Pages : 838
Get Book Here
Book Description
Author:
Publisher:
ISBN:
Category : Nuclear energy
Languages : en
Pages : 1622
Get Book Here
Book Description
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309130395
Category : Medical
Languages : en
Pages : 220
Get Book Here
Book Description
This book is the product of a congressionally mandated study to examine the feasibility of eliminating the use of highly enriched uranium (HEU2) in reactor fuel, reactor targets, and medical isotope production facilities. The book focuses primarily on the use of HEU for the production of the medical isotope molybdenum-99 (Mo-99), whose decay product, technetium-99m3 (Tc-99m), is used in the majority of medical diagnostic imaging procedures in the United States, and secondarily on the use of HEU for research and test reactor fuel. The supply of Mo-99 in the U.S. is likely to be unreliable until newer production sources come online. The reliability of the current supply system is an important medical isotope concern; this book concludes that achieving a cost difference of less than 10 percent in facilities that will need to convert from HEU- to LEU-based Mo-99 production is much less important than is reliability of supply.
Author:
Publisher:
ISBN:
Category : Nuclear reactors
Languages : en
Pages : 156
Get Book Here
Book Description
Author: U.S. Atomic Energy Commission. Division of Technical Information
Publisher:
ISBN:
Category : Nuclear energy
Languages : en
Pages : 900
Get Book Here
Book Description
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309445310
Category : Medical
Languages : en
Pages : 264
Get Book Here
Book Description
The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are used worldwide for medical diagnostic imaging or therapy. The United States consumes about half of the world's supply of Mo-99, but there has been no domestic (i.e., U.S.-based) production of this isotope since the late 1980s. The United States imports Mo-99 for domestic use from Australia, Canada, Europe, and South Africa. Mo-99 and Tc-99m cannot be stockpiled for use because of their short half-lives. Consequently, they must be routinely produced and delivered to medical imaging centers. Almost all Mo-99 for medical use is produced by irradiating highly enriched uranium (HEU) targets in research reactors, several of which are over 50 years old and are approaching the end of their operating lives. Unanticipated and extended shutdowns of some of these old reactors have resulted in severe Mo-99 supply shortages in the United States and other countries. Some of these shortages have disrupted the delivery of medical care. Molybdenum-99 for Medical Imaging examines the production and utilization of Mo-99 and associated medical isotopes, and provides recommendations for medical use.
